Thu.Apr 11, 2024

article thumbnail

$10 billion long Covid ‘moonshot’ is being floated by Bernie Sanders 

STAT

WASHINGTON — Bernie Sanders is pushing for a long Covid “moonshot.” He released a draft legislative proposal this week, a follow up to a milestone hearing in January that sounded the alarm on long Covid as a pressing public health crisis. The pitch calls for $10 billion in mandatory funding over the next decade to establish a new long Covid research program at the National Institutes of Health.

363
363
article thumbnail

How pharma’s surging M&A is impacting the industry’s tech sector

PharmaVoice

As dealmaking in biopharma picks up, the CEO of eClinical Solutions sees an opportunity for clinical software companies to make acquisitions easier to close.

114
114
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Medicare expects to spend $3.5 billion on new Alzheimer’s drug in 2025

STAT

Medicare for the first time has estimated that a new Alzheimer’s treatment could cost the program billions of dollars by next year — well beyond what Wall Street or even the drug’s manufacturer have projected — according to a document obtained by STAT. Medicare’s actuaries expect the drug Leqembi , made by the Japanese drugmaker Eisai and sold in partnership with Biogen, to cost the traditional Medicare program around $550 million in 2024, and the entire Medica

article thumbnail

FDA Releases Guidance on Data Integrity for In Vivo Bioavailability and Bioequivalence Studies

PharmaTech

The draft guidance provides recommendations for data integrity for clinical and bioanalytical portions of bioavailability and bioequivalence studies submitted with drug applications.

116
116
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

STAT+: When a cancer drug fails, oncologists often fly blind. A precision technique might light the way

STAT

It seemed as if Logan Jenner had the best possible chance for a cure. Diagnosed at age 3 with acute myeloid leukemia, an aggressive blood cancer, Logan happened to have a targetable mutation that occurs in a small minority of childhood AML cases, making it possible for him to receive a precision therapy drug that — with chemotherapy — got him to a point where he could receive a bone marrow transplant.

article thumbnail

How to overcome hurdles to HCP and patient adoption of digital health initiatives

pharmaphorum

Discover effective strategies to overcome barriers to healthcare providers (HCP) and patients adopting digital health initiatives like apps. Learn how to increase engagement and improve outcomes.

117
117

More Trending

article thumbnail

Researchers call to reduce repeat antibiotic prescriptions for respiratory tract infections

Pharma Times

RTIs account for around 60% of global antibiotic prescribing and are a key driver of AMR

146
146
article thumbnail

Opinion: To rebuild trust in public health: Better communication, fewer mandates, and small wins

STAT

It’s no surprise in today’s corrosive political environment that trust in government is near an all-time low. That’s a big problem. Communities with more trust during the Covid-19 pandemic had fewer deaths and less economic devastation. In many countries — notably the United States — the pandemic dissolved trust between parts of the community and the public health system.

article thumbnail

Patent expiration to drive biosimilars market expansion to 2032

European Pharmaceutical Review

Expirations of biologic patents has enabled manufacturers to enter the market and offer lower-cost alternatives of these drugs, [which has] resulted in increased competition and price pressure, driving the growth of the biosimilar market” A report published by Towards Healthcare has estimated that the global biosimilar market will value $1,26,019.67 million by 2032, at 17.6 percent CAGR between 2023 and 2032.

article thumbnail

STAT+: European Parliament votes in favor of updated pharma legislation, prompting mixed reactions

STAT

The European Parliament has voted overwhelmingly to adopt legislation that is supposed to transform the way medicines are brought to market and accessed across much of Europe. But the effort — which must still be approved by the European Council — drew mixed reactions from the pharmaceutical industry and consumer groups. A key sticking point concerns data protection.

298
298
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Is the pharmaceutical sector realising its potential for sustainable manufacturing?

European Pharmaceutical Review

The pharmaceutical industry is becoming increasingly conscious of emissions and the importance of sustainable manufacturing. Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available. 1 That’s more than the automotive sector, which released 46.4 megatonnes in the same year, and the increased demand and complexity of medicines since then will only have swollen this figure. 1 Every major pharmaceutical manufact

article thumbnail

STAT+: FTC cracks down on telehealth addiction service Monument for sharing health data

STAT

On Thursday, the Federal Trade Commission took action against alcohol addiction telehealth company Monument, affirming its promise to crack down on digital health companies’ misuse of personal health data. Monument revealed health information to third parties including Meta and Google without users’ consent, the FTC alleged , while misleading users into thinking their health data was kept confidential.

293
293
article thumbnail

How to Become a Nurse Later in Life 

Board Vitals - Pharmacist

Embarking on a career in the nursing field later in life is an inspiring journey that many individuals choose to undertake. Whether it’s a personal passion or a long-held dream, it’s never too late to pursue a fulfilling career in healthcare. In this guide, we will answer the most common questions asked by those starting a nursing career later in life.

article thumbnail

Listen: Vertex’s big deal, biotech’s red numbers, & an industry history lesson

STAT

How would you spend $13 billion in cash? Is biotech stale? And remember Dendreon? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss a multibillion-dollar deal from Vertex Pharmaceuticals with sweeping implications and a lengthy backstory. We also explain why gas prices are weighing on biotech, and make a surprise announcement.

270
270
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Green shoots and cautious optimism: Insights from BIO-Europe Spring

pharmaphorum

Discover the latest insights and trends from BIO-Europe Spring conference, focusing on green shoots and cautious optimism in the industry. Learn about the latest funding opportunities and more.

109
109
article thumbnail

STAT+: The inside story of Enhertu’s pan-tumor approval

STAT

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox. Good morning! The first quarter was the fourth-best quarter for biotech financing on record, according to Jefferies. But stubbornly high inflation doesn’t bode well for the interest rate cuts that the biotech market was seeking.

234
234
article thumbnail

UK study finds screening with a PSA test in prostate cancer can lead to overdiagnosis

Pharma Times

Prostate cancer is responsible for around 12,000 deaths a year in the UK and is the second biggest cause of death for men

116
116
article thumbnail

STAT+: Pharmalittle: We’re reading about drug shortages, Medicare spending on an Alzheimer’s drug, and more

STAT

Hello, everyone, and how are you today? We are doing just fine, thank you, despite the cloudy skies hovering over the unusually quiet Pharmalot campus. While the sun may not be shining, we will rely on sage advice from the Morning Mayor, who reminded us that every new day should be unwrapped like a precious gift. So while you tug on the ribbon, we will brew another cup of stimulation.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

PCPA joins calls for healthcare protection in conflict areas

The Pharmacist

The Primary Care Pharmacy Association (PCPA) has joined other healthcare organisations in calling for the safeguarding of healthcare facilities and personnel in areas of conflict. Dr Graham Stretch, PCPA president, told The Pharmacist that he signed the open letter, coordinated by the World Health Professions Alliance, last week following a short discussion with the PCPA executive committee. […] The post PCPA joins calls for healthcare protection in conflict areas appeared first on The Pha

101
101
article thumbnail

Gas prices are hurting biotech

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a look at a biotech deal with a lengthy backstory, the tyranny of gas prices, and the latest shakeup at BIO.

article thumbnail

EU pharma reform package clears key Parliament vote

pharmaphorum

The European Parliament has voted through reforms to legislation regulating the pharma sector, which the industry claims could compromise competitiveness and patient care.

Packaging 104
article thumbnail

Low dose injectable could aid prenatal depression

European Pharmaceutical Review

A new clinical study has demonstrated that when administered immediately post-childbirth, one low dose injection of esketamine reduced major depressive episodes in individuals with prenatal depression. Based on the data, the researchers concluded that low dose esketamine should be considered in mothers with symptoms of prenatal depression. In mothers with prenatal depressive symptoms , a single low dose of esketamine given shortly after childbirth decreased major depressive episodes at 42 days p

95
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

FDA puts breakthrough tag on Roche, Lilly Alzheimer’s test

pharmaphorum

Roche and Eli Lilly have been granted breakthrough status by the FDA for their pTau217 blood test for Alzheimer's disease.

119
119
article thumbnail

Innovative Financing Models for Repurposing Generic Drugs

Drug Patent Watch

A paper presented at the 2nd International Conference on Systems Medicine, AI, and Drug Repurposing proposes a novel approach to overcoming the financial barriers associated with repurposing generic drugs through… Source

94
article thumbnail

Novartis adds clinical-stage protein degrader from Arvinas

pharmaphorum

Novartis accelerates its protein degrader programmes by licensing a phase 3-ready prostate cancer candidate from Arvinas in a deal worth over $1 billion

110
110
article thumbnail

Landmark study validates Cystic Fibrosis drug for infants as young as four weeks old

Outsourcing Pharma

In a groundbreaking revelation, a study conducted by RCSI University of Medicine and Health Sciences and Childrenâs Health Ireland has confirmed the safety and efficacy of a Cystic Fibrosis drug in newborns as young as four weeks old.

94
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Pharmacist in practice: 'Training and practice are intertwined'

The Pharmacist

Amardeep Singh began his career in community pharmacy, but now works as a senior GP Pharmacist in Wolverhampton. He is also a co-founder of One PCN Training, which provides clinical training to pharmacists and other primary care staff. Here, he tells The Pharmacist how he carved out a role as a pharmacist in general practice […] The post Pharmacist in practice: 'Training and practice are intertwined' appeared first on The Pharmacist.

article thumbnail

Asahi Kasei Bioprocess and Axolabs partner to accelerate oligonucleotide therapeutics development

Express Pharma

Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics. The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility spanning an area of 59,000 square feet (approximately 5,481 square meters) in Berlin.

88
article thumbnail

NICE recommends first oral treatment for migraine prevention

The Pharmacist

New guidance from NICE will give 170,000 people in England more treatment options for preventing migraine attacks. The final draft guidance recommends that patients with both chronic and episodic migraines should be offered treatment with atogepant, the first oral preventative treatment option available for patients who suffer from migraines. The medication, made by AbbVie, is […] The post NICE recommends first oral treatment for migraine prevention appeared first on The Pharmacist.

86
article thumbnail

Adragos Pharma - poised to make a lasting impact in the pharmaceutical industry

Outsourcing Pharma

Adragos Pharma is a contract development and manufacturing organization (CDMO) that provides development and manufacturing services for drug products. It concentrates on small molecule dosage forms including sterile and non-sterile liquids, solids, and semi-solids products.

Dosage 87
article thumbnail

UK’s NICE recommends AbbVie’s Aquipta to treat migraines

Pharmaceutical Technology

The oral drug, which gained UK approval in September 2023, is used for the prevention of both chronic and episodic migraines.

97